BEAT
HeartBeam Inc

3,607
Mkt Cap
$59.02M
Volume
76,001.00
52W High
$3.48
52W Low
$0.9101
PE Ratio
-2.40
BEAT Fundamentals
Price
$1.67
Prev Close
$1.72
Open
$1.71
50D MA
$1.63
Beta
1.28
Avg. Volume
89,953.83
EPS (Annual)
-$0.7299
P/B
13.59
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
HeartBeam Earnings Preview
read more...
Benzinga·16h ago
News Placeholder
More News
News Placeholder
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Thursday, November 13...
Business Wire·14d ago
News Placeholder
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a partnership with HeartNexus, Inc., a...
Business Wire·16d ago
News Placeholder
HeartBeam Announces Exercise and Closing of Underwriters Over-Allotment Option for Public Offering of Common Stock
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the underwriter of its previously...
Business Wire·9mo ago
News Placeholder
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that it has priced its public offering...
Business Wire·9mo ago
News Placeholder
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to...
Business Wire·10mo ago
News Placeholder
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it will attend the JP Morgan 2025 Annual...
Business Wire·11mo ago
News Placeholder
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the US Food and Drug Administration...
Business Wire·11mo ago
News Placeholder
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced the results from two...
Business Wire·1y ago
News Placeholder
HeartBeam Reports Third Quarter 2024 Results
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its financial and operational results for...
Business Wire·1y ago

Latest BEAT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.